Clinical and Experimental Pediatrics

대한소아청소년과학회 (The Korean Pediatric Society)
권호 표지
DOI QR코드

DOI QR Code

24개월 이상 소아에서 요로 감염의 원인균과 항생제 감수성의 양상 : 6년간 단일 기관 경험

Microbiological spectrum and antibiotic susceptibility pattern in more than 24-month-old children with urinary tract infection: A6-year retrospective, single center experience

  • 고정희 (한림대학교 의과대학 소아과학교실) ;
  • 이지현 (한림대학교 의과대학 소아과학교실) ;
  • 심은정 (한림대학교 의과대학 소아과학교실) ;
  • 조도준 (한림대학교 의과대학 소아과학교실) ;
  • 민기식 (한림대학교 의과대학 소아과학교실) ;
  • 유기양 (한림대학교 의과대학 소아과학교실) ;
  • 이대형 (한림대학교 의과대학 소아과학교실) ;
  • 강희정 (한림대학교 의과대학 진단검사의학과학교실)
  • Ko, Jeong Hee (Departments of Pediatrics, College of Medicine, Hallym University) ;
  • Lee, Jee Hyun (Departments of Pediatrics, College of Medicine, Hallym University) ;
  • Sim, Eun Jung (Departments of Pediatrics, College of Medicine, Hallym University) ;
  • Cho, Do Jun (Departments of Pediatrics, College of Medicine, Hallym University) ;
  • Min, Ki Sik (Departments of Pediatrics, College of Medicine, Hallym University) ;
  • Yoo, Ki Yang (Departments of Pediatrics, College of Medicine, Hallym University) ;
  • Lee, Dae Hyoung (Departments of Pediatrics, College of Medicine, Hallym University) ;
  • Kang, Hee Jung (Departments of Laboratory Medicine, College of Medicine, Hallym University)
  • 투고 : 2009.05.21
  • 심사 : 2009.09.03
  • 발행 : 2009.10.15
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

목 적:본 연구의 목적은 2003년부터 2008년까지 24개월 이상 소아 요로 감염 원인균의 분포와 변화를 알아보고 주요 원인균인 Escherichia coli의 항생제 감수성의 시간에 따른 변화를 알아보고자 하였다. 방 법:2003년 1월에서 2008년 12월까지 본원에 열성 요로 감염으로 입원하여 치료받은 24개월 이상 환아의 기록을 후향적으로 분석하였다. 소변 배양 검사에서 단일 세균이 $10^5CFU/mL$ 이상인 경우에 유의하다고 보고 원인 균주와 항생제 감수성을 분석하였다. E. coli의 항생제 감수성의 변화 유무를 확인하기 위해 두 시기(A군: 2003-2005, B군: 2006-2008)로 나누어 chi-square test for trend를 사용하였다. 결 과:환아들로부터 63례의 균주가 분리되었다. 가장 흔한 원인균은 E. coli로 77.8%의 빈도를 보였다. 원인균들의 시기별 분포는 유의한 차이가 없었다(P>0.05). E. coli의 항생제 감수성은 aztreonam, cefotetan, cefotaxime, ceftriaxone, cefepime, amikacin, imipenem에 대하여 90% 이상, trimethoprim/sulfamethoxazole에 대하여 49%, ampicillin과 ampicillin/sulbactam에 대하여 20-25% 이었다. 두 시기 동안 E. coli의 감수성은 대부분 항생제에 대하여 변화가 없었으나, cefuroxime에 대한 감수성은 74.1%에서 95.5%로 증가하였고(P=0.006), ciprofloxacin에 대한 감수성은 59.3%에서 86.4%로 증가하였다(P=0.039). 결 론:E. coli 및 다른 그람 음성균은 trimethoprim/sulfamethoxazole, ampicillin, ampicillin/sulbactam에 감수성이 낮아 단독으로 요로 감염의 초기 경험적 항생제로 사용하는 것은 부적절하다고 생각되며, 적절한 경험적 항생제의 선택은 그 지역 사회의 원인균에 대한 지속적인 감시와 항생제 감수성의 결과에 근거를 두어야 하겠다.

Purpose:To characterize the pathogens and their antibiotic susceptibilities in more than 24-month-old children with urinary tract infection (UTI) and to study the Escherichia coli antimicrobial susceptibility trend. Methods:We retrospectively reviewed the record of more than 24-month-old children with UTI between January 2003 and December 2008. Positive results for 1 bacterial species with a colony count of ${\geq}10^5CFU/mL$ was considered statistically significant. We analyzed uropathogens and their antibiotic susceptibilities. To investigate E. coli antibiotic susceptibility trend, we compared 2 study periods (group A: 2003-2005 versus group B: 2006-2008) using the chi-square test for trend. Results:In all, 63 bacterial isolates were identified in children with febrile UTI. The most common pathogen was E. coli (77.8%). There was no difference in the resistance patterns of uropathogens during the 2 study periods (P>0.05). Antibiotic susceptibility of the E. coli isolates to aztreonam, cefotetan, cefotaxime, ceftriaxone, cefepime, amikacin, and imipenem was >90% to trimethoprim/sulfamethoxazol, 49% and to ampicillin and ampicillin/sulbactam, 20-25%. Over the 2 study period, the E. coli susceptibilities to most antibiotics did not change: the susceptibility to cefuroxime increased from 74.1% to 95.5% (P=0.046) and that to ciprofloxacin increased from 59.3% to 86.4% (P=0.039). Conclusion:Empirical treatment with trimethoprim/sulfamethoxazole, ampicillin, and ampicillin/sulbactam alone appeared to be insufficient in childhood UTI because of the high resistance of E. coli and other gram-negative uropathogens. Antibiotics for empirical therapy should be selected based on the sensitivity and resistance pattern of uropathogens found in a particular region.

키워드

참고문헌

  1. Elder JS. Urinary tract infections. In : Kliegman RM, Behrman RE, Jensen HB, Stanton BF, editors. Nelson textbook of pediatrics, 18th ed. Philadelphia: WB Saunders Co, 2007:2223-8
  2. Hoberman A, Chao HP, Keller DM, Hickey R, Davis HW, Ellis D. Prevalence of urinary tract infection in febrile infants. J Pediatr 1993;123:17-23 https://doi.org/10.1016/S0022-3476(05)81531-8
  3. Baraff LJ. Management of fever without source in infants and children. Ann Emerg Med 2000;36:602-14 https://doi.org/10.1067/mem.2000.110820
  4. Rushton HG. Urinary tract infections in children. epidemiology, evaluation, and management. Pediatr Clin North Am 1997;44: 1133-69 https://doi.org/10.1016/S0031-3955(05)70551-4
  5. Erb A, Sturmer T, Marre R, Brenner H. Prevalence of antibiotic resistance in Escherichia coli: Overview of geographical, temporal, and methodological variations. Eur J Clin Microbiol Infect Dis 2007;26:83-90 https://doi.org/10.1007/s10096-006-0248-2
  6. Bauer R, Kogan BA. New developments in the diagnosis and management of pediatric UTIs. Urol Clin North Am 2008;35: 47-58 https://doi.org/10.1016/j.ucl.2007.09.007
  7. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing: 16th informational supplement. Document M100-S16. Wayne, PA; CLSI, 2006
  8. Kang YD, Kim NS, Oh SH. Causative organisms of urinary tract infection in children, and their antibiotic susceptibility. Korean J Pediatr 2004;47:1065-71
  9. Kim NH, Lee JA, Kim YK, Choi EH, Ha IS, Lee HJ, et al. Risk factors of urinary tract infections due to extended- spectrum beta-lactamase producing Escherichia coli in children. Korean J Pediatr 2004;47:164-9
  10. Lee YK, Lee HC, Chun JM, Yoon SY, Lee WG, Shin SM. Antibiotic sensitivity to the major causative organisms of acute urinary tract infection in children. Korean J Pediatr 2005;48:760-5
  11. Kwon YD, Kim MJ, Kim HU, Oh SH, Song JY, Ko JT, et al. Antibiotic sensitivity pattern of pathogens from children with UTI. J Korean Soc Pediatr Nephrol 2006;10:182-91
  12. Song YH, Kim DH, Park JY, Choi CH, Cho EY, Kim SM, et al. Escherichia coli susceptibility to antimicrobials in children with urinary tract infection. J Korean Soc Pediatr Nephrol 2006;10:192-200
  13. Kang MJ, Shin HK, Yim HE, Je BK, Eun SH, Choi BM, et al. Urinary tract infections in infants under six months of age. Korean J Pediatr 2006;49:278-86 https://doi.org/10.3345/kjp.2006.49.3.278
  14. Jung HJ, Aum JA, Jung SJ, Huh JW. Different characteristic between Escherichia coli and non-Escherichea coli urinary tract infection. Korean J Pediatr 2007;50:457-61 https://doi.org/10.3345/kjp.2007.50.5.457
  15. Chi HM, Kwahk JH, Lee JH, Park HW. Incidence of Escherichia coli and its susceptibility to antimicrobials in childhood urinary tract infection. J Korean Soc Pediatr Nephrol 2006; 10:18-26
  16. Marcus N, Ashkenazi S, Yaari A, Samra Z, Livni G. Non- Escherichia coli versus Escherichia coli community-acquired urinary tract infections in children hospitalized in a tertiary center: Relative frequency, risk factors, antimicrobial resistance and outcome. Pediatr Infect Dis J 2005;24:581-5 https://doi.org/10.1097/01.inf.0000168743.57286.13
  17. Sharifian M, Karimi A, Tabatabaei SR, Anvaripour N. Microbial sensitivity pattern in urinary tract infections in children: A single center experience of 1,177 urine cultures. Jpn J Infect Dis 2006;59:380-2
  18. Prelog M, Schiefecker D, Fille M, Wurzner R, Brunner A, Zimmerhackl LB. Febrile urinary tract infection in children: Ampicillin and trimethoprim insufficient as empirical mono- therapy. Pediatr Nephrol 2008;23:597-602 https://doi.org/10.1007/s00467-007-0701-1
  19. Gaspari RJ, Dickson E, Karlowsky J, Doern G. Antibiotic resistance trends in paediatric uropathogens. Int J Antimicrob Agents 2005;26:267-71 https://doi.org/10.1016/j.ijantimicag.2005.07.009
  20. Abelson Storby K, Osterlund A, Kahlmeter G. Antimicrobial resistance in Escherichia coli in urine samples from children and adults: A 12 year analysis. Acta Paediatr 2004;93:487-91 https://doi.org/10.1080/08035250410023034
  21. Haller M, Brandis M, Berner R. Antibiotic resistance of urinary tract pathogens and rationale for empirical intravenous therapy. Pediatr Nephrol 2004;19:982-6 https://doi.org/10.1007/s00467-004-1528-7
  22. Yuksel S, Ozturk B, Kavaz A, Ozcakar ZB, Acar B, Guriz H, et al. Antibiotic resistance of urinary tract pathogens and evaluation of empirical treatment in turkish children with urinary tract infections. Int J Antimicrob Agents 2006;28:413-6 https://doi.org/10.1016/j.ijantimicag.2006.08.009
  23. Ladhani S, Gransden W. Increasing antibiotic resistance among urinary tract isolates. Arch Dis Child 2003;88:444-5 https://doi.org/10.1136/adc.88.5.444
  24. Karaca Y, Coplu N, Gozalan A, Oncul O, Citil BE, Esen B. Co-trimoxazole and quinolone resistance in Escherichia coli isolated from urinary tract infections over the last 10 years. Int J Antimicrob Agents 2005;26:75-7 https://doi.org/10.1016/j.ijantimicag.2005.03.012
  25. Bronzwaer SL, Cars O, Buchholz U, Molstad S, Goettsch W, Veldhuijzen IK, et al. A European study on the relationship between antimicrobial use and antimicrobial resistance. Emerg Infect Dis 2002;8:278-82 https://doi.org/10.3201/eid0803.010192
  26. Lee JW, Shin JS, Seo JW, Lee MA, Lee SJ. Incidence and risk factors for extended-spectrum beta-lactamase-producing Escherichia coli in community-acquired childhood urinary tract infection. J Korean Soc Pediatr Nephrol 2004;8:214-22
  27. American Academy of Pediatrics. Committee on Quality Improvement. Subcommittee on Urinary Tract Infection. Practice parameter: The diagnosis, treatment, and evaluation of the initial urinary tract infection in febrile infants and young children. Pediatrics 1999;103:843-52 https://doi.org/10.1542/peds.103.4.843

피인용 문헌

  1. Antibiotic Sensitivity Patterns in Children with Urinary Tract Infection: Retrospective Study Over 8 Years in a Single Center vol.23, pp.1, 2009, https://doi.org/10.3339/jkspn.2019.23.1.22